Cory R. Heilmann - Concepedia

Author

Cory R. Heilmann

Eli Lilly (United States)

Also Known As

C Heilmann, C. Heilmann, C. R. Heilmann, C.R. Heilmann, CORY HEILMANN, Cory Heilmann, Cory R Heilmann, Cory R. Heilmann

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)University of North Carolina at Chapel Hill Dallas Diabetes Research Center Tris Pharma (United States)Masonic Medical Research Laboratory

About

Cory R. Heilmann is an author at Eli Lilly (United States) specializing in medicine, physiology, and diabetes.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	790
2	Diabetes	2	2	593
3	Engineering	1	1	197
4	Health Sciences	1	1	34
5	Biomedical Engineering	1	1	197

Cory R. Heilmann

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study John B. Buse, Michael A. Nauck, Thomas Först, The Lancet Diabetes ManagementDiabetesType 2PharmacotherapyDiabetes Mellitus	2012	559
Use of Twice-Daily Exenatide in Basal Insulin–Treated Patients With Type 2 Diabetes John B. Buse, Richard M. Bergenstal, Leonard C. Glass, Annals of Internal Medicine	2011	503
Transmural heterogeneity of calcium activity and mechanical function in the canine left ventricle Jonathan M. Cordeiro, Lindsey A. Greene, Cory R. Heilmann, American Journal of Physiology-Heart and Circulatory Physiology Cardiac MuscleHeart FailureEngineeringBiomedical EngineeringCardiovascular Function	2004	197
Effects of Sodium Channel Block with Mexiletine to Reverse Action Potential Prolongation in In Vitro Models of the Long QT Syndrome Serge Sicouri, Daniel Antzelevitch, Cory R. Heilmann, Journal of Cardiovascular Electrophysiology	1997	75
Baseline Factors Associated With Glycemic Control and Weight Loss When Exenatide Twice Daily Is Added to Optimized Insulin Glargine in Patients With Type 2 Diabetes Julio Rosenstock, Sylvia Shenouda, Richard M. Bergenstal, Diabetes Care	2012	67
Effects of exenatide twice daily versus sitagliptin on 24‐h glucose, glucoregulatory and hormonal measures: a randomized, double‐blind, crossover study Jolene Kay Berg, Sylvia Shenouda, Cory R. Heilmann, Diabetes Obesity and Metabolism	2011	56
Treatment with the glucagon receptor antagonist <scp>LY2409021</scp> increases ambulatory blood pressure in patients with type 2 diabetes Christof Kazda, Juan P. Frías, Irene Foga, Diabetes Obesity and Metabolism	2017	38
Proinsulin, insulin, and C-peptide in cystic fibrosis after an oral glucose tolerance test. Hartling Sg, S. Garne, Christoph Binder, PubMed Metabolic SyndromeBody CompositionMedicineInsulin ManagementPhysiology	1988	34
Guidance on the implementation and reporting of a drug safety Bayesian network meta‐analysis David Ohlssen, Karen Price, H. Amy Xia, Pharmaceutical Statistics	2013	30
Proof of the Double Bubble Conjecture in R<sup>4</sup>and certain higher dimensional cases Ben W. Reichardt, Cory R. Heilmann, Yuan Y. Lai, Pacific Journal of Mathematics Geometry Of NumberDiscrete GeometryStandard Double BubblePhysicsHigher Dimensional Problem	2003	26

Page 1